Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026
Same author

Structure-function multilayer network integration and cognition in multiple sclerosis.

Network neuroscience (Cambridge, Mass.)·2026
Same author

Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes.

Therapeutic advances in neurological disorders·2026
Same author

The cytokine signature in multiple sclerosis: a study during the SARS-CoV-2 pandemic.

Frontiers in immunology·2026
Same author

EDSS and disease duration associate with progression independent of relapse and MRI activity in natalizumab-treated multiple sclerosis patients.

Multiple sclerosis and related disorders·2026
Same journal

Hypogonadotrophic hypogonadism in GBA2 associated spastic paraplegia type 46 (SPG46): a phenotypic expansion.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Vibrotactile stimulation induces changes in basal ganglia output, cervical muscle activity, and head posture in a patient with cervical dystonia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Neuropsychological assessment in adult epilepsy: rationale, test selection, and clinical integration across non-surgical care in Italian patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Early implementation of transradial mechanical thrombectomy in a primary stroke center: a sequential cohort propensity score-matched study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Cyclophosphamide-based combination therapies for autoimmunity.

Paola Perini1, Massimiliano Calabrese, Luciano Rinaldi

  • 1Multiple Sclerosis Centre-Veneto Region, Department of Neuroscience, University Hospital, Via Giustiniani 5, 35128, Padova, Italy.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|October 4, 2008
PubMed
Summary
This summary is machine-generated.

Intense immunosuppression using cyclophosphamide (Cyc) can halt irreversible disability in multiple sclerosis (MS) patients unresponsive to other treatments. Combining Cyc with therapies like interferon beta (IFNbeta) offers further options for severe autoimmune diseases.

Related Experiment Videos

Last Updated: Jul 2, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Area of Science:

  • Neuroimmunology
  • Autoimmune disease research
  • Clinical immunology

Background:

  • Multiple sclerosis (MS) can lead to rapid, irreversible disability, especially when unresponsive to immunomodulatory agents (IMAs).
  • Effective treatment for refractory MS is crucial to prevent disease progression and severe disability.
  • Intense immunosuppressive therapies offer a potential strategy to manage aggressive, treatment-resistant MS.

Purpose of the Study:

  • To evaluate the efficacy of cyclophosphamide (Cyc)-based immunosuppression for IMA-refractory multiple sclerosis (MS).
  • To explore the use of combined Cyc and interferon beta (IFNbeta) protocols for IFNbeta-unresponsive MS.
  • To investigate novel therapeutic combinations for severe autoimmune diseases.

Main Methods:

  • Review of clinical data on patients with rapidly deteriorating, IMA-refractory MS treated with cyclophosphamide (Cyc).
  • Analysis of outcomes for MS patients treated with combined Cyc and interferon beta (IFNbeta) protocols.
  • Overview of ongoing clinical trials investigating Cyc combinations in severe autoimmune diseases.

Main Results:

  • Cyclophosphamide (Cyc)-based intense immunosuppression has shown success in arresting disease activity in rapidly deteriorating, IMA-refractory MS patients.
  • Therapeutic protocols combining Cyc and interferon beta (IFNbeta) have been effective in treating IFNbeta-unresponsive MS.
  • Combinations of Cyc with other immunomodulatory drugs or monoclonal antibodies are under investigation for severe autoimmune conditions.

Conclusions:

  • Intense immunosuppression, particularly with cyclophosphamide (Cyc), is a viable strategy for managing aggressive, treatment-resistant multiple sclerosis (MS).
  • Combination therapies involving Cyc demonstrate promise for refractory MS and other severe autoimmune diseases.
  • Further clinical trials are warranted to explore the full potential of Cyc-based regimens in autoimmune disease management.